These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 34774497)

  • 1. 5-Benzylidene, 5-benzyl, and 3-benzylthiazolidine-2,4-diones as potential inhibitors of the mitochondrial pyruvate carrier: Effects on mitochondrial functions and survival in Drosophila melanogaster.
    Touaibia M; St-Coeur PD; Duff P; Faye DC; Pichaud N
    Eur J Pharmacol; 2021 Dec; 913():174627. PubMed ID: 34774497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thiazolidinediones are acute, specific inhibitors of the mitochondrial pyruvate carrier.
    Divakaruni AS; Wiley SE; Rogers GW; Andreyev AY; Petrosyan S; Loviscach M; Wall EA; Yadava N; Heuck AP; Ferrick DA; Henry RR; McDonald WG; Colca JR; Simon MI; Ciaraldi TP; Murphy AN
    Proc Natl Acad Sci U S A; 2013 Apr; 110(14):5422-7. PubMed ID: 23513224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a mitochondrial target of thiazolidinedione insulin sensitizers (mTOT)--relationship to newly identified mitochondrial pyruvate carrier proteins.
    Colca JR; McDonald WG; Cavey GS; Cole SL; Holewa DD; Brightwell-Conrad AS; Wolfe CL; Wheeler JS; Coulter KR; Kilkuskie PM; Gracheva E; Korshunova Y; Trusgnich M; Karr R; Wiley SE; Divakaruni AS; Murphy AN; Vigueira PA; Finck BN; Kletzien RF
    PLoS One; 2013; 8(5):e61551. PubMed ID: 23690925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The beneficial metabolic effects of insulin sensitizers are not attenuated by mitochondrial pyruvate carrier 2 hypomorphism.
    Vigueira PA; McCommis KS; Hodges WT; Schweitzer GG; Cole SL; Oonthonpan L; Taylor EB; McDonald WG; Kletzien RF; Colca JR; Finck BN
    Exp Physiol; 2017 Aug; 102(8):985-999. PubMed ID: 28597936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial pyruvate carrier inhibitors improve metabolic parameters in diet-induced obese mice.
    Hodges WT; Jarasvaraparn C; Ferguson D; Griffett K; Gill LE; Chen Y; Ilagan MXG; Hegazy L; Elgendy B; Cho K; Patti GJ; McCommis KS; Finck BN
    J Biol Chem; 2022 Feb; 298(2):101554. PubMed ID: 34973337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of 5-(substituted benzylidene)thiazolidine-2,4-dione derivatives as novel tyrosinase inhibitors.
    Ha YM; Park YJ; Kim JA; Park D; Park JY; Lee HJ; Lee JY; Moon HR; Chung HY
    Eur J Med Chem; 2012 Mar; 49():245-52. PubMed ID: 22301213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A highly responsive pyruvate sensor reveals pathway-regulatory role of the mitochondrial pyruvate carrier MPC.
    Arce-Molina R; Cortés-Molina F; Sandoval PY; Galaz A; Alegría K; Schirmeier S; Barros LF; San Martín A
    Elife; 2020 Mar; 9():. PubMed ID: 32142409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterisation of a new class of highly specific and potent inhibitors of the mitochondrial pyruvate carrier.
    Hildyard JC; Ammälä C; Dukes ID; Thomson SA; Halestrap AP
    Biochim Biophys Acta; 2005; 1707(2-3):221-30. PubMed ID: 15863100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, characterization and biological evaluation of some novel 2,4-thiazolidinediones as potential cytotoxic, antimicrobial and antihyperglycemic agents.
    Avupati VR; Yejella RP; Akula A; Guntuku GS; Doddi BR; Vutla VR; Anagani SR; Adimulam LS; Vyricharla AK
    Bioorg Med Chem Lett; 2012 Oct; 22(20):6442-50. PubMed ID: 22981328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for new inhibitors of the human Mitochondrial Pyruvate Carrier and their effects on hepatic glucose production and diabetes.
    Herzig S; Li L; Jiménez-Sánchez C; Martinou JC; Maechler P
    Biochim Biophys Acta Gen Subj; 2023 Dec; 1867(12):130492. PubMed ID: 37871770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of multi-substituted benzylidenethiazolidine-2,4-diones on LDL oxidation.
    Jeong TS; Kim JR; Kim KS; Cho KH; Bae KH; Lee WS
    Bioorg Med Chem; 2004 Aug; 12(15):4017-23. PubMed ID: 15246079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial pyruvate carrier-mediated metabolism is dispensable for the classical activation of macrophages.
    Ran L; Zhang S; Wang G; Zhao P; Sun J; Zhou J; Gan H; Jeon R; Li Q; Herrmann J; Wang F
    Nat Metab; 2023 May; 5(5):804-820. PubMed ID: 37188821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Novel Mitochondrial Pyruvate Carrier Inhibitors to Treat Hair Loss.
    Liu X; Flores AA; Situ L; Gu W; Ding H; Christofk HR; Lowry WE; Jung ME
    J Med Chem; 2021 Feb; 64(4):2046-2063. PubMed ID: 33534563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyruvate fuels mitochondrial respiration and proliferation of breast cancer cells: effect of monocarboxylate transporter inhibition.
    Diers AR; Broniowska KA; Chang CF; Hogg N
    Biochem J; 2012 Jun; 444(3):561-71. PubMed ID: 22458763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic Strategies of Thiazolidine-2,4-dione Derivatives for the Development of New Anti-diabetic Agents: Compressive Review.
    Ray PK; Shabana K; Salahuddin ; Kumar R
    Curr Top Med Chem; 2024; 24(10):885-928. PubMed ID: 38500288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial metabolism of pyruvate is essential for regulating glucose-stimulated insulin secretion.
    Patterson JN; Cousteils K; Lou JW; Manning Fox JE; MacDonald PE; Joseph JW
    J Biol Chem; 2014 May; 289(19):13335-46. PubMed ID: 24675076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-Aryl thiazolidine-2,4-diones as selective PPARgamma agonists.
    Koyama H; Boueres JK; Han W; Metzger EJ; Bergman JP; Gratale DF; Miller DJ; Tolman RL; MacNaul KL; Berger JP; Doebber TW; Leung K; Moller DE; Heck JV; Sahoo SP
    Bioorg Med Chem Lett; 2003 May; 13(10):1801-4. PubMed ID: 12729668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of mitochondrial pyruvate carrier blocker UK5099 creates metabolic reprogram and greater stem-like properties in LnCap prostate cancer cells in vitro.
    Zhong Y; Li X; Yu D; Li X; Li Y; Long Y; Yuan Y; Ji Z; Zhang M; Wen JG; Nesland JM; Suo Z
    Oncotarget; 2015 Nov; 6(35):37758-69. PubMed ID: 26413751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, biological evaluation and in silico studies of 5-(3-methoxybenzylidene)thiazolidine-2,4-dione analogues as PTP1B inhibitors.
    Mahapatra MK; Kumar R; Kumar M
    Bioorg Chem; 2017 Apr; 71():1-9. PubMed ID: 28126289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Hepatic Mitochondrial Pyruvate Carrier as a Regulator of Systemic Metabolism and a Therapeutic Target for Treating Metabolic Disease.
    McCommis KS; Finck BN
    Biomolecules; 2023 Jan; 13(2):. PubMed ID: 36830630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.